-
Loading metrics
Open Access
Peer-reviewed
Research Article
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
-
Janice M. Leung,
Affiliations Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada, Division of Respiratory Medicine, Department of Medicine, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Virginia Chen,
Affiliation PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Zsuzsanna Hollander,
Affiliation PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Darlene Dai,
Affiliation PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Scott J. Tebbutt,
Affiliations Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada, Division of Respiratory Medicine, Department of Medicine, St. Paul’s Hospital, Vancouver, British Columbia, Canada, PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Shawn D. Aaron,
Affiliation Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
⨯ -
Kathy L. Vandemheen,
Affiliation Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
⨯ -
Stephen I. Rennard,
Affiliations Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, AstraZeneca, Cambridge, United Kingdom
⨯ -
J. Mark FitzGerald,
Affiliation Division of Respiratory Medicine, Department of Medicine, Vancouver General Hospital and the Institute for Heart and Lung Health, Vancouver, British Columbia, Canada
⨯ -
Prescott G. Woodruff,
Affiliation Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, United States of America
⨯ -
Stephen C. Lazarus,
Affiliation Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, United States of America
⨯ -
John E. Connett,
Affiliation University of Minnesota, Minneapolis, Minnesota, United States of America
⨯ -
Harvey O. Coxson,
Affiliation Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Bruce Miller,
Affiliation GlaxoSmithKline Research and Development, King of Prussia, Pennsylvania, United States of America
⨯ -
Christoph Borchers,
Affiliation University of Victoria-Genome British Columbia Proteomics Centre, Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada
⨯ -
Bruce M. McManus,
Affiliations Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada, PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ -
Raymond T. Ng,
Affiliation PROOF Center of Excellence, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ - [ ... ],
-
Don D. Sin
* E-mail: Don.Sin@hli.ubc.ca
Affiliations Centre for Heart Lung Innovation, St. Paul’s Hospital, Vancouver, British Columbia, Canada, Division of Respiratory Medicine, Department of Medicine, St. Paul’s Hospital, Vancouver, British Columbia, Canada
⨯ - [ view all ]
- [ view less ]
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
- Janice M. Leung,
- Virginia Chen,
- Zsuzsanna Hollander,
- Darlene Dai,
- Scott J. Tebbutt,
- Shawn D. Aaron,
- Kathy L. Vandemheen,
- Stephen I. Rennard,
- J. Mark FitzGerald,
- Prescott G. Woodruff
- Published: August 15, 2016
- https://doi.org/10.1371/journal.pone.0161129